LIPOCINE INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
LIPOCINE INC. (LPCN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-10
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2021-03-31 was 0.00%.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2020-03-31 was 0.00%.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2017-03-31 was 0.00%.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-10 | |||||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-10 | |||||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-13 | |||||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-07 | |||||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-09 | |||||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-10 | |||||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-10 | |||||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-09 | |||||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-09 | |||||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-06 | |||||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-06 | |||||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-11 | |||||
| 2019-09-30 | 0.00% 10-Q · filed 2020-11-10 | |||||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-06 | |||||
| 2018-12-31 | 8212.00% 10-K · filed 2019-03-06 | |||||
| 2018-09-30 | 0.00% 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | 0.00% 10-Q · filed 2019-08-07 | 8212.00% 10-Q · filed 2018-08-07 | ||||
| 2017-12-31 | 8212.00% 10-K · filed 2019-03-06 | 0.00% 10-K · filed 2018-03-12 | ||||
| 2017-09-30 | 0.00% 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | 8212.00% 10-Q · filed 2018-08-07 | 0.00% 10-Q · filed 2017-08-07 | ||||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-08 | |||||
| 2016-12-31 | 8212.00% 10-K · filed 2019-03-06 | 0.00% 10-K · filed 2017-03-06 | ||||
| 2016-09-30 | 0.00% 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | 0.00% 10-Q · filed 2017-08-07 | |||||
| 2016-03-31 | 0.00% 10-Q · filed 2016-05-09 | |||||
| 2015-12-31 | 0.00% 10-K · filed 2018-03-12 | |||||
| 2015-09-30 | 0.00% 10-Q · filed 2016-11-08 | |||||
| 2015-06-30 | 0.00% 10-Q · filed 2016-08-09 | |||||
| 2015-03-31 | 0.00% 10-Q · filed 2015-05-07 | |||||
| 2014-12-31 | 0.00% 10-K · filed 2017-03-06 | |||||
| 2014-09-30 | 0.00% 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | 0.00% 10-Q · filed 2015-08-11 | |||||
| 2014-03-31 | 0.00% 10-Q · filed 2014-05-13 | |||||
| 2013-12-31 | 0.00% 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |